Showing results (71-80 of 79) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Adjuvant immunization of HLA-A2-positive melanoma patients with a modified gp100 peptide induces peptide-specific CD8+ T-cell responsesJohn W Smith, Edwin B Walker, Bernard A Fox, et al.Clinical Breast Cancer|May 17, 2011
Sunitinib plus paclitaxel versus bevacizumab plus paclitaxel for first-line treatment of patients with advanced breast cancer: a phase III, randomized, open-label trialNicholas J Robert, Mansoor N Saleh, Devchand Paul, et al.Studies in Health Technology and Informatics|January 13, 2006
Reification of abstract concepts to improve comprehension using interactive virtual environments and a knowledge-based design: a renal physiology modelDale C Alverson, Stanley M Saiki, Thomas P Caudell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2003
Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trialJoseph I Clark, Michael B Atkins, Walter J Urba, et al.Clinical Breast Cancer|October 4, 2016
Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5John W Smith, Marc E Buyse, Priya Rastogi, et al.BMJ Open|February 22, 2024
Recent innovations in long-term care coverage and financing: a rapid scoping reviewMarilyn Macdonald, Lori E Weeks, Erin Langman, et al.NPJ Breast Cancer|June 12, 2021
Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patientsCostanza Paoletti, Meredith M Regan, Samuel M Niman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2004
Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinomaDavid F McDermott, Meredith M Regan, Joseph I Clark, et al.European Journal of Cancer (Oxford, England : 1990)|March 10, 2023
Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trialFrankie A Holmes, Beverly Moy, Suzette Delaloge, et al.Pageof 8